Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Clémence Loiseau"'
Autor:
Clémence Loiseau, Jacques Augenstreich, Adrienne Marchand, Etienne Harté, Martine Garcia, Julien Verdon, Marc Mesnil, Sophie Lecomte, Jean-Marc Berjeaud
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162007 (2016)
Antimicrobial peptides can be used as therapeutic agents against cancer cells. Warnericin RK and derivatives (WarnG20D and WarnF14V) were tested on various, solid tumor or leukemia, cancer cells. These peptides appeared to be cytotoxic on all the cel
Externí odkaz:
https://doaj.org/article/6a0e1630e35e4506889bb0080151f6e7
Autor:
Yosr Hicheri, Célestine Simand, Xavier Thomas, Patrice Chevallier, Maria-Pilar Gallego-Hernanz, Emmanuel Raffoux, Marie-Anne Couturier, Thibaut Leguay, Mathilde Hunault Berger, Céline Berthon, Colombe Saillard, Françoise Huguet, Marie-Christine Béné, Clémence Loiseau
Publikováno v:
Leukemia & Lymphoma. 62:620-629
We retrospectively examined the results of a new chemo-free approach combining blinatumomab with ponatinib (blina/pona) in 26 relapsed/refractory Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patients. All but one achieved complete m
Publikováno v:
Blood Adv
Treatment-free remission (TFR) is an opportunity for patients with chronic myeloid leukemia (CML). Reported cumulative incidence curves of molecular recurrence (MRec) arbor a 2-phase shape with mainly early events, but also some late events (late MRe
Autor:
Xavier Thomas, Chantal Himberlin, Anne Banos, Clémence Loiseau, Emmanuel Raffoux, Corentin Orvain, Amine Belhabri, Isabelle Luquet, Christian Recher, Mathilde Hunault, Norbert Vey, Pierre Peterlin, Sylvain Chantepie, Christine Terré, Claude Gardin, Ariane C Mineur, Eric Delabesse, Cécile Pautas, Claude Preudhomme, Romain Guieze, Jean Francois Hamel, Emilie Lemasle, Martin Carre, Karine Celli-Lebras, Arnaud Pigneux, Hervé Dombret, Jean-Francois Brasme, Marc Bernard
Publikováno v:
Blood. 136:10-11
In spite of CR rates of 75-80% currently achieved with anthracycline-cytarabine regimens in younger patients with favorable and intermediate-risk AML, relapse remains a major issue. The French AML intergroup launched the BIG-1 trial in 2015 in order
Autor:
Etienne Lengliné, Emmanuel Raffoux, Didier Bouscary, Matteo Dragani, Nicolas Boissel, Raphael Itzykson, Philippe Rousselot, Madalina Uzunov, Jean Michel Cayuela, Rathana Kim, Hervé Dombret, Felipe Suarez, Delphine Rea, Clémence Loiseau
Publikováno v:
Blood. 136:35-36
Introduction :Since the introduction of tyrosine kinase inhibitors (TKIs) the prognosis of Philadelphia positive (Ph+) diseases like chronic myeloid leukemia (CML) dramatically improved (Sasaki K, Lancet Haematol 2015). Nonetheless, myeloid blastic c
Autor:
Caroline Besson, Clémence Loiseau, Philippe Rousselot, Jean-Michel Cayuela, Marc Delord, Marc Spentchian
Publikováno v:
Blood. 134:27-27
Background. The A-STIM (According to Stop IMatinib, NCT1038732) observational study established the loss of major molecular response (loss of MMR, BCR-ABL1 IS >0.1%) as a practical and safe criterion for restarting therapy in patients with CML who ha
Autor:
Clémence, Loiseau, Emilie, Portier, Marie-Hélène, Corre, Margot, Schlusselhuber, Ségolène, Depayras, Jean-Marc, Berjeaud, Julien, Verdon
Publikováno v:
BioMed Research International
Legionella pneumophila, the causative agent of Legionnaires' disease, is a waterborne bacterium mainly found in man-made water systems in close association with free-living amoebae and multispecies biofilms. Pseudomonas strains, originating from vari
Autor:
Clémence Loiseau, Raphael Itzykson, Emilie Catherinot, Jean-Paul Vernant, Marie Hélène Becquemin, Madalina Uzunov, Odile Randrianarivelo, Hélène Salvator, Nathalie Dhedin, Colas Tcherakian, Stéphanie Nguyen, Louis Jean Couderc, Laurent Sutton, François Lemonnier, Elisabeth Rivaud, Philippe Devillier
Publikováno v:
The European respiratory journal. 52(1)
Long-term outcome of patients with BOS post HSCT with home spirometry is encouraging despite suboptimal adherence
Autor:
Adrienne Marchand, Julien Verdon, Jacques Augenstreich, Etienne Harté, Jean-Marc Berjeaud, Clémence Loiseau, Marc Mesnil, Sophie Lecomte, Martine Garcia
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2016, 11 (9), pp.e0162007. ⟨10.1371/journal.pone.0162007⟩
PLoS ONE, Vol 11, Iss 9, p e0162007 (2016)
PLoS ONE, Public Library of Science, 2016, 11 (9), pp.e0162007. ⟨10.1371/journal.pone.0162007⟩
PLoS ONE, Vol 11, Iss 9, p e0162007 (2016)
peptide warnericin RK; International audience; Antimicrobial peptides can be used as therapeutic agents against cancer cells. Warnericin RK and derivatives (WarnG20D and WarnF14V) were tested on various, solid tumor or leukemia, cancer cells. These p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6a21e2926cac842cd1cb5882001d7db
https://hal.archives-ouvertes.fr/hal-01437455
https://hal.archives-ouvertes.fr/hal-01437455
Autor:
Julien Verdon, Sylvie Chevalier, Clémence Loiseau, Willy Aucher, Olivier Lesouhaitier, Margot Schlusselhuber, Emilie Portier, Jean-Marc Berjeaud
Publikováno v:
Frontiers in Microbiology
Frontiers in Microbiology, Frontiers Media, 2016, 7, pp.486. ⟨10.3389/fmicb.2016.00486⟩
Frontiers in Microbiology, Vol 7 (2016)
Frontiers in Microbiology, Frontiers Media, 2016, 7, pp.486. ⟨10.3389/fmicb.2016.00486⟩
Frontiers in Microbiology, Vol 7 (2016)
International audience; Legionella pneumophila, the major causative agent of Legionnaires' disease, is found in freshwater environments in close association with free-living amoebae and multispecies biofilms, leading to persistence, spread, biocide r